Enzon Pharmaceuticals Inc (ENZN)
0.0834
0.00 (0.00%)
USD |
OTCM |
Apr 26, 13:33
Enzon Pharmaceuticals Cash and Short Term Investments (Quarterly): 47.01M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 47.01M |
| September 30, 2023 | 46.56M |
| June 30, 2023 | 46.13M |
| March 31, 2023 | 45.88M |
| December 31, 2022 | 46.98M |
| September 30, 2022 | 46.85M |
| June 30, 2022 | 46.79M |
| March 31, 2022 | 47.43M |
| December 31, 2021 | 47.64M |
| September 30, 2021 | 47.89M |
| June 30, 2021 | 48.19M |
| March 31, 2021 | 48.19M |
| December 31, 2020 | 48.14M |
| September 30, 2020 | 5.311M |
| June 30, 2020 | 5.909M |
| March 31, 2020 | 5.144M |
| December 31, 2019 | 5.446M |
| September 30, 2019 | 10.02M |
| June 30, 2019 | 3.367M |
| March 31, 2019 | 3.558M |
| December 31, 2018 | 6.50M |
| September 30, 2018 | 6.726M |
| June 30, 2018 | 6.966M |
| March 31, 2018 | 7.24M |
| December 31, 2017 | 7.478M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.32M |
| June 30, 2017 | 11.21M |
| March 31, 2017 | 8.079M |
| December 31, 2016 | 7.639M |
| September 30, 2016 | 12.90M |
| June 30, 2016 | 11.23M |
| March 31, 2016 | 9.735M |
| December 31, 2015 | 11.67M |
| September 30, 2015 | 20.26M |
| June 30, 2015 | 38.99M |
| March 31, 2015 | 34.80M |
| December 31, 2014 | 34.56M |
| September 30, 2014 | 28.99M |
| June 30, 2014 | 21.48M |
| March 31, 2014 | 14.86M |
| December 31, 2013 | 6.52M |
| September 30, 2013 | 21.69M |
| June 30, 2013 | 14.46M |
| March 31, 2013 | 199.31M |
| December 31, 2012 | 196.74M |
| September 30, 2012 | 278.44M |
| June 30, 2012 | 129.15M |
| March 31, 2012 | 124.69M |
| December 31, 2011 | 162.51M |
| September 30, 2011 | 330.24M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
3.367M
Minimum
Jun 2019
48.19M
Maximum
Jun 2021
34.15M
Average
46.79M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 13.07M |
| Perspective Therapeutics Inc | 9.238M |
| Protalix BioTherapeutics Inc | 44.56M |
| Electromed Inc | 10.43M |
| Armata Pharmaceuticals Inc | 13.52M |